Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease

Ser Haematol. 1973;6(2):202-43.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Blood Sedimentation
  • Cyclophosphamide / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology
  • Hodgkin Disease / radiotherapy
  • Hodgkin Disease / therapy*
  • Humans
  • Male
  • Mechlorethamine / therapeutic use
  • Methotrexate / therapeutic use
  • Prednisone / therapeutic use
  • Procarbazine / therapeutic use
  • Prognosis
  • Radiotherapy Dosage
  • Radiotherapy, High-Energy
  • Remission, Spontaneous
  • Splenectomy
  • Time Factors
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Cyclophosphamide
  • Prednisone
  • Methotrexate